| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 213 | 237 | 249 | 250 | 248 | 287 | 284 | 264 | 267 | 324 | 334 | 297 | 382 | 374 | 349 | 401 | 396 | 405 | 412 | 429 | 417 | 478 | 461 | 462 | 425 | 432 | 404 | 386 | 431 |
| Expenses | 206 | 224 | 238 | 224 | 230 | 260 | 255 | 239 | 227 | 268 | 272 | 250 | 300 | 300 | 285 | 329 | 337 | 345 | 337 | 363 | 365 | 410 | 405 | 401 | 384 | 392 | 399 | 391 | 420 |
| EBITDA | 7 | 13 | 11 | 26 | 18 | 27 | 30 | 25 | 40 | 56 | 62 | 47 | 82 | 74 | 65 | 72 | 60 | 60 | 74 | 66 | 52 | 68 | 56 | 61 | 42 | 40 | 6 | -5 | 10 |
| Operating Profit % | 3 % | 5 % | 4 % | 9 % | 7 % | 9 % | 10 % | 9 % | 15 % | 17 % | 18 % | 15 % | 21 % | 19 % | 18 % | 18 % | 15 % | 15 % | 18 % | 15 % | 12 % | 13 % | 12 % | 9 % | 10 % | 9 % | 1 % | -2 % | 2 % |
| Depreciation | 17 | 18 | 18 | 20 | 17 | 18 | 18 | 18 | 19 | 19 | 17 | 19 | 22 | 20 | 19 | 18 | 20 | 16 | 17 | 18 | 20 | 21 | 24 | 26 | 28 | 29 | 29 | 29 | 30 |
| Interest | 7 | 5 | 4 | 5 | 6 | 5 | 7 | 8 | 6 | 6 | 6 | 5 | 4 | 3 | 4 | 3 | 4 | 5 | 7 | 9 | 8 | 8 | 10 | 12 | 14 | 18 | 16 | 18 | 26 |
| Profit Before Tax | -12 | -10 | 4 | 9 | -0 | 10 | 11 | 8 | 24 | 37 | 38 | 34 | 61 | 65 | 51 | 60 | 48 | 67 | 38 | 39 | 34 | 46 | 23 | 33 | 7 | -5 | -31 | -46 | -37 |
| Tax | 0 | -3 | -1 | -2 | -2 | 2 | 2 | 2 | 7 | 11 | 12 | 9 | 22 | 23 | 18 | 19 | 10 | 18 | 10 | 13 | 10 | 11 | 7 | 11 | 5 | 5 | -3 | -4 | -0 |
| Net Profit | -12 | -7 | 5 | 12 | 2 | 8 | 9 | 5 | 17 | 26 | 25 | 25 | 40 | 42 | 33 | 41 | 39 | 50 | 28 | 26 | 24 | 35 | 16 | 22 | 2 | -10 | -28 | -41 | -36 |
| EPS in ₹ | -1.32 | -0.81 | 0.57 | 1.25 | 0.20 | 0.85 | 0.99 | 0.58 | 1.85 | 2.78 | 2.75 | 2.71 | 4.30 | 4.52 | 3.58 | 4.39 | 4.19 | 5.40 | 3.05 | 2.80 | 2.62 | 3.82 | 1.69 | 2.39 | 0.20 | -1.09 | -3.08 | -4.48 | -3.94 |
Indoco Remedies
Indoco Remedies
285.20
-6.90
(-2.36%)
Key Fundamentals
Market Cap
2,694.60 Cr
EPS
-8.46
PE Ratio
-22.68
Dividend Yield
0.07 %
Industry
Healthcare 52 Week High
355.00
52 Week Low
190.00
PB Ratio
2.58
Debt to Equity
0.78
Sector
Pharmaceuticals Analyst Rating and Forecast
- By Refinitiv from5 analysts
Actual
Company News
View All News
Indoco Remedies Receives Zero Observations from USFDA Inspection at Patalganga API Facility
Sep 19, 2025
Sep 19, 2025The USFDA completed an inspection of Indoco Remedies' API manufacturing facility at Patalganga with zero observations. The company views this outcome as a reflection of its commitment to quality and regulatory compliance.
Indoco Remedies has entered into a sale and leaseback agreement valued at ₹24.65 crore with OPC Asset Solution. The agreement covers the company's Waluj facility and Anacipher CRO, with the lease arrangement extending until 2035.
Indoco Remedies Sets September 4 Record Date for Rs. 0.20 Final DividendAug 14, 2025
Indoco Remedies Limited has set September 4, 2025, as the record date for determining shareholder eligibility for a final dividend of Rs. 0.20 per equity share for the financial year ended March 31, 2025. The company's share transfer books will be closed from September 5-11, 2025, for the AGM and dividend payment purposes. The dividend was recommended by the Board of Directors on May 22, 2025, and is subject to shareholder approval at the 78th Annual General Meeting scheduled for September 11, 2025. If approved, the dividend will be paid within 30 days after tax deduction. The company has also fixed September 4, 2025, as the cut-off date for remote e-voting and e-voting during the AGM.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,679.10 | #1 3,98,049.70 | 38.75 | #1 54,729.00 | 9.71 | #1 10,980 | -19.84 | 61.71 | |
6,621.50 | 1,75,222.50 | 76.19 | 9,712.00 | 18.67 | 2,191 | 26.74 | 72.60 | |
1,577.60 | 1,26,768.90 | 23.67 | 28,409.50 | 7.12 | 5,291 | 9.88 | 60.63 | |
3,584.30 | 1,19,599.80 | 60.49 | 11,539.40 | 6.99 | 1,911 | 19.91 | 53.74 | |
1,255.90 | 1,03,508.80 | #1 18.25 | 33,741.20 | 16.73 | 5,725 | 1.26 | 48.97 | |
2,476.60 | 1,01,344.60 | 53.48 | 12,744.20 | #1 20.90 | 2,007 | -18.14 | 47.04 | |
987.65 | 99,073.80 | 21.09 | 23,511.00 | 18.55 | 4,615 | 2.60 | 45.37 | |
1,940.00 | 89,121.90 | 23.79 | 22,909.50 | 13.74 | 3,306 | #1 51.64 | 46.82 | |
5,581.50 | 66,047.70 | 28.61 | 13,458.30 | 3.70 | 2,216 | 21.39 | 63.11 | |
1,101.00 | 64,254.10 | 19.04 | 32,345.60 | 9.43 | 3,484 | -10.24 | 50.87 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
-8.58 %
Net Income Growth
-180.41 %
Cash Flow Change
-38.91 %
ROE
-187.53 %
ROCE
-104.41 %
EBITDA Margin (Avg.)
-54.92 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 846 | 941 | 1,197 | 1,238 | 1,258 | 1,272 | 1,315 | 1,486 | 1,658 | 2,145 | 2,430 |
| Fixed Assets | 340 | 374 | 440 | 489 | 468 | 590 | 570 | 555 | 678 | 954 | 997 |
| Current Assets | 385 | 465 | 572 | 539 | 538 | 563 | 623 | 774 | 814 | 955 | 1,001 |
| Capital Work in Progress | 63 | 55 | 91 | 136 | 185 | 51 | 68 | 122 | 114 | 125 | 321 |
| Investments | 0 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 9 | 2 |
| Other Assets | 443 | 496 | 666 | 614 | 605 | 631 | 677 | 809 | 864 | 1,057 | 1,111 |
| Total Liabilities | 846 | 941 | 1,197 | 1,238 | 1,258 | 1,272 | 1,315 | 1,486 | 1,658 | 2,145 | 2,430 |
| Current Liabilities | 262 | 303 | 390 | 417 | 446 | 459 | 407 | 425 | 425 | 612 | 808 |
| Non Current Liabilities | 65 | 61 | 155 | 146 | 152 | 133 | 139 | 157 | 205 | 422 | 604 |
| Total Equity | 519 | 577 | 651 | 675 | 661 | 680 | 769 | 905 | 1,028 | 1,111 | 1,018 |
| Reserve & Surplus | 500 | 558 | 633 | 657 | 642 | 661 | 751 | 886 | 1,010 | 1,092 | 1,004 |
| Share Capital | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 1 | -0 | 50 | -52 | 12 | 3 | -14 | 8 | -7 | 4 | -3 |
| Investing Activities | -88 | -111 | -171 | -135 | -104 | -56 | -67 | -121 | -208 | -432 | -339 |
| Operating Activities | 109 | 112 | 89 | 123 | 132 | 123 | 82 | 174 | 179 | 155 | 95 |
| Financing Activities | -20 | -2 | 132 | -39 | -16 | -64 | -30 | -44 | 23 | 280 | 241 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 58.69 % | 58.69 % | 58.69 % | 58.69 % | 58.69 % | 58.69 % | 58.69 % | 58.69 % | 58.69 % | 58.74 % | 58.74 % | 58.72 % | 58.75 % | 58.75 % | 58.80 % | 58.90 % | 58.90 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.12 % | 0.12 % | 1.59 % | 1.69 % | 1.91 % | 1.47 % | 1.70 % | 1.25 % | 1.24 % | 1.22 % |
| DIIs | 18.88 % | 18.80 % | 17.22 % | 17.23 % | 17.64 % | 17.52 % | 17.33 % | 18.07 % | 17.29 % | 17.78 % | 19.56 % | 19.41 % | 18.67 % | 18.24 % | 18.90 % | 18.75 % | 18.96 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 15.92 % | 15.92 % | 17.32 % | 17.87 % | 17.87 % | 17.23 % | 16.85 % | 16.74 % | 16.48 % | 16.84 % | 15.24 % | 15.33 % | 16.29 % | 16.30 % | 16.07 % | 15.99 % | 15.79 % |
| Others | 6.52 % | 6.59 % | 6.78 % | 6.21 % | 5.80 % | 6.57 % | 7.13 % | 6.39 % | 7.42 % | 5.04 % | 4.77 % | 4.62 % | 4.81 % | 5.01 % | 4.99 % | 5.12 % | 5.14 % |
| No of Share Holders | 21,508 | 24,518 | 34,746 | 37,279 | 37,863 | 38,498 | 38,072 | 35,713 | 34,731 | 36,588 | 32,600 | 33,201 | 34,511 | 34,416 | 34,676 | 34,497 | 33,129 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 1.6 | 1 | 0.3 | 0.3 | 1.5 | 2.25 | 2.25 | 1.5 | 0.2 |
| Dividend Yield (%) | 0.00 | 0.75 | 0.49 | 0.14 | 0.1 | 0.4 | 0.69 | 0.68 | 0.64 | 0.07 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 06 Nov 2025 |  Quarterly Result Announcement | NA | 06 Nov 2025 | 296.85 | 285.20 |
| 21 Sept 2021 |  Dividend | ₹ 1.50 /share | 17 Sept 2021 | 358.65 | 473.05 |
| 16 Sept 2022 | Dividend | ₹ 0.75 /share | 14 Sept 2022 | 331.60 | 359.35 |
| 15 Sept 2022 | Dividend | ₹ 1.50 /share | 14 Sept 2022 | 331.60 | 365.20 |
| 19 Sept 2023 | Dividend | ₹ 2.25 /share | 18 Sept 2023 | 347.80 | 356.80 |
| 19 Sept 2024 | Dividend | ₹ 1.50 /share | 19 Sept 2024 | 327.55 | 369.65 |
| 26 Sept 2024 |  Annual General Meeting | NA | 26 Sept 2024 | 365.50 | 365.50 |
| 24 Oct 2024 | Quarterly Result Announcement | NA | 24 Oct 2024 | 336.65 | 319.95 |
| 21 Jan 2025 | Quarterly Result Announcement | NA | 21 Jan 2025 | 326.65 | 335.15 |
| 22 May 2025 | Quarterly Result Announcement | NA | 22 May 2025 | 251.12 | 261.58 |
| 24 Jul 2025 | Quarterly Result Announcement | NA | 24 Jul 2025 | 325.90 | 310.05 |
| 04 Sept 2025 | Dividend | ₹ 0.20 /share | 04 Sept 2025 | 261.58 | 282.60 |
| 11 Sept 2025 | Annual General Meeting | NA | 11 Sept 2025 | 293.70 | 276.85 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation2 days ago
2 days ago Clarification To BSE- Movement In Volume5 days ago
5 days agoClarification sought from Indoco Remedies Ltd5 days ago
5 days agoBoard Meeting Intimation for Intimation Of Board Meeting Under Reg 29 Of SEBI (LODR) Regulations 20155 days ago
5 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20189 days ago
9 days agoClosure of Trading WindowSep 30, 2025
Sep 30, 2025Announcement under Regulation 30 (LODR)-Credit RatingSep 25, 2025
Sep 25, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 19, 2025
Sep 19, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 19, 2025
Sep 19, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 12, 2025
Sep 12, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 11, 2025
Sep 11, 2025Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsAug 30, 2025
Aug 30, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 29, 2025
Aug 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 15, 2025
Aug 15, 2025Business Responsibility and Sustainability Reporting (BRSR)Aug 14, 2025
Aug 14, 2025Reg. 34 (1) Annual Report.Aug 14, 2025
Aug 14, 2025Notice Of 78Th Annual General Meeting And Annual Report For The Financial Year 2024-25Aug 14, 2025
Aug 14, 2025Intimation Of Cut-Off Date For E-Voting Book Closure And Record Date For DividendAug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 09, 2025
Aug 09, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 08, 2025
Aug 08, 2025Announcement under Regulation 30 (LODR)-Credit RatingAug 04, 2025
Aug 04, 2025Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsAug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJul 28, 2025
Jul 28, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 25, 2025
Jul 25, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 24, 2025
Jul 24, 2025Financial Results For The Quarter Ended 30Th June 2025Jul 24, 2025
Jul 24, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 24Th July 2025Jul 24, 2025
Jul 24, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 24, 2025
Jul 24, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 16, 2025
Jul 16, 2025Board Meeting Intimation for Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter Ended 30-06-2025.Jul 14, 2025
Jul 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2025
Jul 09, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 03, 2025
Jul 03, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 03, 2025
Jul 03, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 03, 2025
Jul 03, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Intimation To Shareholders Holding Shares In Physical Mode Regarding Mandatory Furnishing Of PAN KYC And Bank Details As Per SEBI Master Circular No. SEBI/HO/MIRSD/POD-1/P/CIR/2024/37 Dated May 07 2024 And SEBI Circular Bearing Reference No. SEBI/HO/MIRSDJun 24, 2025
Jun 24, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 19, 2025
Jun 19, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 13, 2025
Jun 13, 2025Announcement Under Regulation 30 (LODR):- Order For Drop Of Proceeding Under GST Act 2017Jun 12, 2025
Jun 12, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 12, 2025
Jun 12, 2025Order For Drop Of ProceedingJun 11, 2025
Jun 11, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 03, 2025
Jun 03, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
May 27, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 26, 2025
May 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 23, 2025
May 23, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 HDFC Multi Cap Fund Direct - Growth | 0.00% | -661080 | -0.10% | -0.11% | |
| HDFC Value Fund Direct Plan-Growth | 0.62% | 652105 | 0.29% | 0.24% | |
 Tata India Pharma & Healthcare Fund Direct-Growth | 0.04% | -409227 | -0.83% | -0.98% | |
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.08% | -15 | 0.01% | -0.01% | |
 DSP Healthcare Fund Direct - Growth | 3.07% | 0 | 0.30% | -0.15% | |
| DSP Multicap Fund Direct - Growth | 0.53% | 0 | 0.03% | -0.07% | |
 Franklin India Small Cap Fund Direct-Growth | 0.45% | 0 | 0.04% | -0.02% | |
 ICICI Prudential Smallcap Fund Direct Plan-Growth | 0.00% | 0 | 0.00% | 0.00% | |
 Nippon India Pharma Fund Direct-Growth | 0.66% | 0 | 0.07% | -0.01% | |
| Nippon India Small Cap Fund Direct- Growth | 0.11% | 0 | 0.00% | -0.02% | |
 Quant Small Cap Fund Direct Plan-Growth | 0.42% | 0 | 0.03% | -0.03% | |
| Tata India Innovation Fund Direct-Growth | 0.53% | 0 | 0.05% | -0.04% |
Technical Indicators
RSI(14)
Neutral 45.61
ATR(14)
Less Volatile 11.92
STOCH(9,6)
Neutral 24.29
STOCH RSI(14)
Neutral 33.05
MACD(12,26)
Bearish -0.65
ADX(14)
Strong Trend 30.01
UO(9)
Bullish 28.46
ROC(12)
Downtrend And Accelerating -2.31
WillR(14)
Oversold -93.46
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
